Novel mechanisms were proven to be exerted by ZOL in ameliorating migraine headache and pain such as decreasing the gene expression of key epigenetically altered genes in migraine; RAMP-1 and NPTX-2, and modulation of the endocannabinoid; CB-1/MAPK pathway. This evidence concerns the gene NPTX2 and migraine disorder.